Long-term safety of Etrasimod in ulcerative colitis: a comprehensive review

Michael Colwill, Sailish Honap, Fernando Magro, Silvio Danese, Laurent Peyrin-Biroulet

Open source

DOI
10.1080/14740338.2026.2759574
Published
2026-11-03
Container
Expert Opinion on Drug Safety
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14740338.2026.2759574,
  title = {Long-term safety of Etrasimod in ulcerative colitis: a comprehensive review},
  author = {Michael Colwill and Sailish Honap and Fernando Magro and Silvio Danese and Laurent Peyrin-Biroulet},
  year = {2026},
  journal = {Expert Opinion on Drug Safety},
  doi = {10.1080/14740338.2026.2759574},
  url = {https://doi.org/10.1080/14740338.2026.2759574}
}

RIS

TY  - JOUR
TI  - Long-term safety of Etrasimod in ulcerative colitis: a comprehensive review
AU  - Michael Colwill
AU  - Sailish Honap
AU  - Fernando Magro
AU  - Silvio Danese
AU  - Laurent Peyrin-Biroulet
PY  - 2026
JO  - Expert Opinion on Drug Safety
DO  - 10.1080/14740338.2026.2759574
UR  - https://doi.org/10.1080/14740338.2026.2759574
ER  - 

APA

Colwill, M., Honap, S., Magro, F., Danese, S., & Peyrin-Biroulet, L. (2026). Long-term safety of Etrasimod in ulcerative colitis: a comprehensive review. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2026.2759574

Source records